HOME › DRUGS › ALOGLIPTIN;PIOGLITAZONE
ACTIVE SUBSTANCE / INN

ALOGLIPTIN;PIOGLITAZONE

Brand name(s): Incresync
EMA LISTED
AUTHORISED
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Alogliptin;Pioglitazone
REGULATORS
EMA
SPONSORS / MAH
Takeda Pharma A/S
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
IncresyncTakeda Pharma A/SAuthorised19/09/2013Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON ALOGLIPTIN;PIOGLITAZONE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →